ELIQUIS is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Apixaban.
| Product ID | 0003-0894_07ff3e00-b2de-4323-b48e-46e90e682e69 | 
| NDC | 0003-0894 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | ELIQUIS | 
| Generic Name | Apixaban | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2012-12-28 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA202155 | 
| Labeler Name | E.R. Squibb & Sons, L.L.C. | 
| Substance Name | APIXABAN | 
| Active Ingredient Strength | 5 mg/1 | 
| Pharm Classes | Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2012-12-28 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA202155 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2017-06-01 | 
| Marketing Category | NDA | 
| Application Number | NDA202155 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2012-12-28 | 
| Marketing Category | NDA | 
| Application Number | NDA202155 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2012-12-28 | 
| Marketing Category | NDA | 
| Application Number | NDA202155 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2012-12-28 | 
| Marketing Category | NDA | 
| Application Number | NDA202155 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2012-12-28 | 
| Marketing End Date | 2017-06-01 | 
| Ingredient | Strength | 
|---|---|
| APIXABAN | 5 mg/1 | 
| SPL SET ID: | e9481622-7cc6-418a-acb6-c5450daae9b0 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0003-0893 | ELIQUIS | apixaban | 
| 0003-0894 | ELIQUIS | apixaban | 
| 0003-3764 | ELIQUIS | apixaban | 
| 50090-1436 | ELIQUIS | apixaban | 
| 50090-1437 | ELIQUIS | apixaban | 
| 55154-0612 | ELIQUIS | apixaban | 
| 70518-1861 | ELIQUIS | ELIQUIS | 
| 55154-0613 | ELIQUIS | ELIQUIS | 
| 63629-7747 | ELIQUIS | ELIQUIS | 
| 67296-1673 | ELIQUIS | ELIQUIS | 
| 14445-149 | apixaban | apixaban | 
| 14445-150 | apixaban | apixaban | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  ELIQUIS  85544142  4451882 Live/Registered | Bristol-Myers Squibb Company 2012-02-16 | 
|  ELIQUIS  78775228  not registered Dead/Abandoned | Pfizer Inc. 2005-12-16 | 
|  ELIQUIS  77933261  not registered Dead/Abandoned | Pfizer Inc. 2010-02-11 | 
|  ELIQUIS  77933259  not registered Dead/Abandoned | BRISTOL-MYERS SQUIBB COMPANY 2010-02-11 | 
|  ELIQUIS  77933257  not registered Dead/Abandoned | Pfizer Inc. 2010-02-11 | 
|  ELIQUIS  77622324  3674414 Live/Registered | BRISTOL-MYERS SQUIBB COMPANY 2008-11-26 | 
|  ELIQUIS  76388645  3066277 Dead/Cancelled | BRISTOL-MYERS SQUIBB COMPANY 2002-02-26 |